Status:
RECRUITING
Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Multiple Myeloma
Olfactivo-gustatory Disorder
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Proposition of a sensory rehabilitation program that could reduce the olfactory-gustatory alterations in patients who have been treated with chemotherapy for Haematological Cancer, and also improve th...
Detailed Description
Disturbances in taste and smell affect a considerable proportion of patients treated with chemotherapy. In hematology, dysgeusia depends on the type pathology and the treatments themselves. It impacts...
Eligibility Criteria
Inclusion
- Age between 18 and ≤ 75 years old
- Patient with olfactory or gustatory disorders
- Patient who has completed chemotherapy for haematological cancer
Exclusion
- Eating disorder known prior to anti-cancer treatment, bulimic, anorexic or binge eating disorder (DSM-V criteria)
- Refusal to sign the free and informed consent
- Hypersensitivity to one of the components of liposomal sprays (Liposaliva® or liponasal®)
- COVID + patient in the previous 3 months
- Performance status ECOG 3 or 4
- Patient included in another clinical trial modifying taste / olfaction
- Artificial nutrition post-chemotherapy
- Known food allergies
- Having a reading level in French that may interfere with a good understanding of the protocol and the questionnaires
- Presenting visual or hearing deficits uncorrected to normal and which may affect the proper completion of the questionnaires
- Patient under curatorship or tutorship.
- Patient deprived of liberty
- Pregnant or breastfeeding patient
- Not be affiliated with a French social security scheme or beneficiary of such a scheme
Key Trial Info
Start Date :
June 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04716153
Start Date
June 25 2021
End Date
December 1 2028
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology Department, University Hospital Center
Montpellier, France, 34 295